Chinaâs biotech is redrawing the global pharma map; what India can learnAmerican biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma treatment. Astr...
16 Mar, 2025, 10.12 AM IST
Dr Reddy's unit ties up with Shanghai Henlius BiotechDr Reddy's Laboratories has partnered with Shanghai Henlius Biotech to develop and commercialize HLX15, a biosimilar to the cancer drug Dar...
06 Feb, 2025, 04.35 PM IST
J&J Q2 Results: Pharma major beats Wall Street estimates on strong drug salesJohnson & Johnson beat estimates for second-quarter profit and revenue on Wednesday, driven by strong sales of its drugs, including cancer ...
17 Jul, 2024, 04.19 PM IST
GSK blood cancer drug nearly halves risk of death in late-stage trialIn the trial of 302 patients with relapsed or difficult-to-treat multiple myeloma, 71% of those who received Blenrep in combination with th...
02 Jun, 2024, 06.01 PM IST
J&J issues cautious 2023 forecast, shares fallThe company was "responsibly optimistic" about 2023, Chief Financial Officer Joseph Wolk said on a conference call, pointing to fierce comp...
18 Apr, 2023, 09.26 PM IST
Johnson & Johnson plans to split into two companiesThe healthcare company will separate its consumer health business into a new publicly traded company and is aiming to complete the planned ...
12 Nov, 2021, 06.43 PM IST
Johnson & Johnson Q1 profit, sales jump, beats Wall Street forecastThe one weak spot was a small drop in consumer health sales, which saw a surge in 2020's first quarter, when nervous consumers stocked up o...
20 Apr, 2021, 10.56 PM IST
J&J beats profit estimates but coronavirus fuels forecast cutJohnson & Johnson is the first major U.S. drugmaker to report earnings since the coronavirus outbreak.
14 Apr, 2020, 06.38 PM IST